CEO Raymond Stevens has emphasized that aleniglipron's manufacturing scalability and its combinability with other therapies, including an oral amylin candidate and PCSK9 inhibitors, differentiate it from injectable incumbents
And thanks for joining us on Rumor vs Truth, your trusted source for facts, where we dissect the evidence behind risky rumors and reveal clinical truths
Neonatal outcomes, including birth weight, gestational age, fetal growth and stay in the neonatal ICU, did not differ between GLP-1 users and controls
Address: 515 Congress Avenue, Unit 1515, Austin, Texas 78701 USA Email: [email protected] Support Line (per published Terms of Use): (512) 960-1075 - Monday through Friday, 8AM-6PM CST Website: jrnys.com Frequently Asked Questions About JRNYS GLP-1 What is JRNYS GLP-1
Food and Drug Administration (FDA)said its aware that some Americans are using unapproved versions of GLP-1 medications, including semaglutide and tirzepatide, as an option for weight loss
